A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE TrialSimon Heller, Carolin Taylor, Mark L. Evans et al.|Health Technology Assessment|2017Cited by 73
Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up studyJames O. Lindsay, John A. Snowden, C J Hawkey et al.|BMC Gastroenterology|2019Cited by 30
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O. Lindsay, John A. Snowden, Daniel Hind et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 19
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, John A. Snowden, Jennifer Petrie et al.|BMJ Open|2024Cited by 10
Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCTJames O. Lindsay, John A. Snowden, Daniel Hind et al.|Efficacy and Mechanism Evaluation|2024Cited by 1